Approvals/CIMA-AEMPS/ROTARIX SUSPENSION ORAL EN APLICADOR ORAL PRECARGADO. VACUNA ANTIRROTAVIRUS, VIVA

Approved

STANDARD

ROTARIX SUSPENSION ORAL EN APLICADOR ORAL PRECARGADO. VACUNA ANTIRROTAVIRUS, VIVA

Glaxosmithkline Biologicals🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 571e521a2db14247
Drug Cima Aemps Name: ROTARIX SUSPENSION ORAL EN APLICADOR ORAL PRECARGADO. VACUNA ANTIRROTAVIRUS, VIVA
Register Number: 05330005IP2
Holder Company Name: Glaxosmithkline Biologicals
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/glaxosmithkline-biologicals
Authorization Date: 2021-05-21
Dosage Form: SUSPENSIÓN ORAL
Dose: 1,5 ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline Biologicals
Company Detail Path: /organization/glaxosmithkline-biologicals

ROTAVIRUS HUMANO

10 MILLONES GERMENES

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 21, 2021

Approval ID

571e521a2db14247

Type

Standard